Phrma Working Group on Adaptive Designs: Introduction to the Full White Paper
Pharmaceutical Research and Manufacturers of America (PhRMA) has formed a Working Group on Adaptive Designs. The group aims to contribute to a constructive dialogue on adaptive designs by engaging statisticians, clinicians, and other stakeholders in academia, regulatory agencies, and industry. Hopef...
Gespeichert in:
| Veröffentlicht in: | Drug information journal 2006-10, Vol.40 (4), p.421-423 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 423 |
|---|---|
| container_issue | 4 |
| container_start_page | 421 |
| container_title | Drug information journal |
| container_volume | 40 |
| creator | Gallo, Paul Krams, Michael |
| description | Pharmaceutical Research and Manufacturers of America (PhRMA) has formed a Working Group on Adaptive Designs. The group aims to contribute to a constructive dialogue on adaptive designs by engaging statisticians, clinicians, and other stakeholders in academia, regulatory agencies, and industry. Hopefully this will facilitate broader consideration and implementation of these designs. The papers that follow in this issue comprise the Full White Paper of the group and summarize its findings and recommendations from its first year of activity. |
| doi_str_mv | 10.1177/216847900604000407 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_275013119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_216847900604000407</sage_id><sourcerecordid>1167451551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-a7e0bc7e246661ce32b881b71fd78bb7c2c294c2f8f54f07e7a5e6bdb0f9c8223</originalsourceid><addsrcrecordid>eNp9kEFLAzEQhYMoWGr_gKeg57WTNLvJeivV1kLFHpQelySbbbe2mzXJCv57U6p4ED0MM8x87w08hC4J3BDC-ZCSTDCeA2TAAGLxE9Q7LBMmgJ1-z5E4RwPvt5GBXKScih56XG7cXuKVda91s8YzZ7sW2waPS9mG-t3gO-PrdeNv8bwJzpadDnU8B4vDxuBpt9vh1aYOBi9la9wFOqvkzpvBV--jl-n98-QhWTzN5pPxItEMREgkN6A0N5RlWUa0GVElBFGcVCUXSnFNNc2ZppWoUlYBN1ymJlOlgirXgtJRH10dfVtn3zrjQ7G1nWviy4LyFMiIkDxC139CLAUuIKc8UvRIaWe9d6YqWlfvpfsoCBSHeIvf8UbR8Cjycm1-bP9RfALcTnhI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>275013119</pqid></control><display><type>article</type><title>Phrma Working Group on Adaptive Designs: Introduction to the Full White Paper</title><source>SAGE Complete A-Z List</source><source>SpringerLink Journals - AutoHoldings</source><creator>Gallo, Paul ; Krams, Michael</creator><creatorcontrib>Gallo, Paul ; Krams, Michael</creatorcontrib><description>Pharmaceutical Research and Manufacturers of America (PhRMA) has formed a Working Group on Adaptive Designs. The group aims to contribute to a constructive dialogue on adaptive designs by engaging statisticians, clinicians, and other stakeholders in academia, regulatory agencies, and industry. Hopefully this will facilitate broader consideration and implementation of these designs. The papers that follow in this issue comprise the Full White Paper of the group and summarize its findings and recommendations from its first year of activity.</description><identifier>ISSN: 2168-4790</identifier><identifier>ISSN: 0092-8615</identifier><identifier>EISSN: 2168-4804</identifier><identifier>EISSN: 2164-9200</identifier><identifier>DOI: 10.1177/216847900604000407</identifier><identifier>CODEN: DGIJB9</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Confidence intervals ; Pharmaceutical industry ; Regulatory agencies ; Sample size ; Statistical methods ; Studies ; Technological change ; Working groups</subject><ispartof>Drug information journal, 2006-10, Vol.40 (4), p.421-423</ispartof><rights>2006 Drug Information Association</rights><rights>Drug Information Association, Inc 2006.</rights><rights>Copyright Drug Information Association 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-a7e0bc7e246661ce32b881b71fd78bb7c2c294c2f8f54f07e7a5e6bdb0f9c8223</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/216847900604000407$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/216847900604000407$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids></links><search><creatorcontrib>Gallo, Paul</creatorcontrib><creatorcontrib>Krams, Michael</creatorcontrib><title>Phrma Working Group on Adaptive Designs: Introduction to the Full White Paper</title><title>Drug information journal</title><description>Pharmaceutical Research and Manufacturers of America (PhRMA) has formed a Working Group on Adaptive Designs. The group aims to contribute to a constructive dialogue on adaptive designs by engaging statisticians, clinicians, and other stakeholders in academia, regulatory agencies, and industry. Hopefully this will facilitate broader consideration and implementation of these designs. The papers that follow in this issue comprise the Full White Paper of the group and summarize its findings and recommendations from its first year of activity.</description><subject>Confidence intervals</subject><subject>Pharmaceutical industry</subject><subject>Regulatory agencies</subject><subject>Sample size</subject><subject>Statistical methods</subject><subject>Studies</subject><subject>Technological change</subject><subject>Working groups</subject><issn>2168-4790</issn><issn>0092-8615</issn><issn>2168-4804</issn><issn>2164-9200</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kEFLAzEQhYMoWGr_gKeg57WTNLvJeivV1kLFHpQelySbbbe2mzXJCv57U6p4ED0MM8x87w08hC4J3BDC-ZCSTDCeA2TAAGLxE9Q7LBMmgJ1-z5E4RwPvt5GBXKScih56XG7cXuKVda91s8YzZ7sW2waPS9mG-t3gO-PrdeNv8bwJzpadDnU8B4vDxuBpt9vh1aYOBi9la9wFOqvkzpvBV--jl-n98-QhWTzN5pPxItEMREgkN6A0N5RlWUa0GVElBFGcVCUXSnFNNc2ZppWoUlYBN1ymJlOlgirXgtJRH10dfVtn3zrjQ7G1nWviy4LyFMiIkDxC139CLAUuIKc8UvRIaWe9d6YqWlfvpfsoCBSHeIvf8UbR8Cjycm1-bP9RfALcTnhI</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Gallo, Paul</creator><creator>Krams, Michael</creator><general>SAGE Publications</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20061001</creationdate><title>Phrma Working Group on Adaptive Designs: Introduction to the Full White Paper</title><author>Gallo, Paul ; Krams, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-a7e0bc7e246661ce32b881b71fd78bb7c2c294c2f8f54f07e7a5e6bdb0f9c8223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Confidence intervals</topic><topic>Pharmaceutical industry</topic><topic>Regulatory agencies</topic><topic>Sample size</topic><topic>Statistical methods</topic><topic>Studies</topic><topic>Technological change</topic><topic>Working groups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallo, Paul</creatorcontrib><creatorcontrib>Krams, Michael</creatorcontrib><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Drug information journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallo, Paul</au><au>Krams, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phrma Working Group on Adaptive Designs: Introduction to the Full White Paper</atitle><jtitle>Drug information journal</jtitle><date>2006-10-01</date><risdate>2006</risdate><volume>40</volume><issue>4</issue><spage>421</spage><epage>423</epage><pages>421-423</pages><issn>2168-4790</issn><issn>0092-8615</issn><eissn>2168-4804</eissn><eissn>2164-9200</eissn><coden>DGIJB9</coden><abstract>Pharmaceutical Research and Manufacturers of America (PhRMA) has formed a Working Group on Adaptive Designs. The group aims to contribute to a constructive dialogue on adaptive designs by engaging statisticians, clinicians, and other stakeholders in academia, regulatory agencies, and industry. Hopefully this will facilitate broader consideration and implementation of these designs. The papers that follow in this issue comprise the Full White Paper of the group and summarize its findings and recommendations from its first year of activity.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><doi>10.1177/216847900604000407</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-4790 |
| ispartof | Drug information journal, 2006-10, Vol.40 (4), p.421-423 |
| issn | 2168-4790 0092-8615 2168-4804 2164-9200 |
| language | eng |
| recordid | cdi_proquest_journals_275013119 |
| source | SAGE Complete A-Z List; SpringerLink Journals - AutoHoldings |
| subjects | Confidence intervals Pharmaceutical industry Regulatory agencies Sample size Statistical methods Studies Technological change Working groups |
| title | Phrma Working Group on Adaptive Designs: Introduction to the Full White Paper |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A05%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phrma%20Working%20Group%20on%20Adaptive%20Designs:%20Introduction%20to%20the%20Full%20White%20Paper&rft.jtitle=Drug%20information%20journal&rft.au=Gallo,%20Paul&rft.date=2006-10-01&rft.volume=40&rft.issue=4&rft.spage=421&rft.epage=423&rft.pages=421-423&rft.issn=2168-4790&rft.eissn=2168-4804&rft.coden=DGIJB9&rft_id=info:doi/10.1177/216847900604000407&rft_dat=%3Cproquest_cross%3E1167451551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=275013119&rft_id=info:pmid/&rft_sage_id=10.1177_216847900604000407&rfr_iscdi=true |